More importantly, as the majority of the PD-1 + CD137+ T-cells have the capacity of expressing IFN-γ, even if this subpopulation of T-cells is small, they may still possess a strong anti-tumor effector T-cell function. This evidence concerns the gene TNFRSF9 and neoplasm.